March 2026: Festival of Biologics

Join KBI Biopharma at Festival of Biologics USA 2026  

Booth #212

When: March 4-5, 2026

Where: San Diego Convention Center, San Diego, CA

Schedule a meeting >>

At KBI Biopharma, we work closely with our clients to deliver fully integrated drug development and biologics manufacturing services. Built on world-class analytics capabilities and deep technical expertise in mammalian systems, we partner with you to develop robust cell lines, optimize processes, and advance your programs from early development through commercial scale.

Whether you're developing complex mAbs, fusion proteins, or next-generation biologics, visit Booth #212 to discuss how we work together with our clients to reduce risk and advance programs forward.

TECH TALK: A Proven Dual Virus Spike Approach for Efficient Viral Clearance Studies

Heather Horne, Director, Program Integration
Wednesday, March 4 | 5:10 PM
Theatre 5

Session overview

Viral clearance studies are essential for biopharmaceutical safety and regulatory compliance. However, traditional single-virus testing is slow, costly, and resource-intensive. Discover how KBI Biopharma and Texcell North America developed a proven dual virus spike approach to streamline these critical studies.

This approach reduced viral spiking study timelines by 50%, equipment and material costs by 28%, and material requirements by approximately 30% compared to traditional testing. By removing barriers that slow drug development, this method helps biopharmaceutical developers bring treatments to patients faster and more efficiently.

View Full Conference Program Here >>

Meet with the KBI Biopharma Team:

Schedule a meeting >>

Chandra Kelley​ 

VP Business Development 

Alejandro Preciado, PhD ​

Sr. Director, Business Development

Justin Smith 

Sr. Director, Marketing ​

Heather Horne, PhD  

Director, Program Integration

Shaunak Uplekar, PhD

Director, Upstream Process Development

 

Jesse Coe, PhD

Associate Director, Business Development, Analytical ​

---

 

Why Stop by the KBI Booth?

Scientific Expertise That Accelerates: Deep technical knowledge across biologics development and manufacturing, combined with regulatory experience that helps move even your most complex programs forward faster.

Continuous Innovation: We continuously explore new technologies to solve real development challenges. For example, our dual viral spike approach reduced viral spiking timelines by 50% and costs by 28%. This commitment to innovation, grounded in regulatory knowledge, is what we bring to your program.

Cell Line Development: Our Selexis® SUREtechnology™ delivers high-producing, stable mammalian cell lines, while our PUREplatform™ provides robust microbial solutions built for high titer and decreased cost of goods that translate efficiently to commercial-scale manufacturing.

Process Development & cGMP Manufacturing: Expert-led process optimization and commercial-scale manufacturing services for mammalian and microbial programs.

Science Driven. Customer Focused.

Ready to discuss your biologics program? Stop by Booth #212 or schedule a one-on-one meeting with our team.

Schedule a meeting >>

 

---

About KBI Biopharma: 

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond. 

Learn more about KBI Biopharma >>

ABOUT THE EVENT: